Streetbeat News

Products Services

CMCSA

DIS

DKNG

The Notre Dame Fighting Irish football team lost to the Ohio State Buckeyes in a game aired on NBC and streamed on Peacock, units of Comcast Corporation (NASDAQ:CMCSA). Actor Vince Vaughn was the featured guest on ESPN College GameDay, a show that airs on Walt Disney Co (NYSE:DIS)-owned ESPN. The game was also a focus for sportsbooks, including DraftKings Inc (NASDAQ:DKNG). Despite the loss, Notre Dame remains a contender for the NCAA Football playoffs and postseason.

Portfolio Pulse from Chris Katje

September 25, 2023 | 11:31 pm

NTES

The upcoming Star Wars game, Star Wars Eclipse, developed by NetEase Inc's Quantic Dream SA, will feature a unique gameplay element where there is no 'game over'. Regardless of the choices players make or which characters die, the game's storyline will continue to progress. The game is set in the High Republic era, hundreds of years before iconic Star Wars characters. The game remains in development.

Portfolio Pulse from Franca Quarneti

September 25, 2023 | 10:18 pm

FEMY

Femasys has received US FDA 510(k) clearance to market FemaSeed, a new infertility treatment solution. This approval could potentially boost the company's market position and revenue.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 9:26 pm

PEGY

Pineapple Energy's subsidiary, SUNation Energy, is expanding its services to Tampa and Central Florida. The company will offer solar installations, battery storage, EV charging services, and SPAN Smart Electrical Panel installations to homeowners in the region.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 9:22 pm

RARE

Ultragenyx Pharmaceutical Inc. has received approval from Health Canada for its drug Evkeeza (evinacumab) as an adjunct to diet and other low-density lipoprotein cholesterol (LDL-C) lowering therapies. The drug, intended for the treatment of adult and pediatric patients aged 5 years and older with homozygous familial hypercholesterolemia (HoFH), will be commercially available in Canada from November 25.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 9:16 pm

TSLA

Tesla Inc's Cybertruck has been spotted on the roads, sparking mixed reactions from the public. Some users on X.com, formerly Twitter, have criticized the design of the vehicle. Elon Musk had previously admitted that there's a chance the Cybertruck could fail due to its unique design. Musk recently confirmed that a delivery event for the Cybertruck will be held later this year, with the company expecting to sell 250,000-500,000 Cybertrucks a year once production is in full swing.

Portfolio Pulse from Aaron Bry

September 25, 2023 | 9:04 pm

ETHUSD

MATICUSD

USDCUSD

Polygon (MATIC) has integrated USDC stablecoin into its blockchain network, marking a step forward in speed and cost efficiency. The integration is not a native launch but an initiation of support for the existing Polygon USDC within the Circle Account and Circle APIs. The proportion of person-to-person transfers in all cross-chain USDC transactions on Polygon has increased from 16% in January 2023 to 40% in June 2023. Circle had previously announced plans to launch USDC for five new blockchain ecosystems in September and a sixth chain, Polygon PoS, in October.

Portfolio Pulse from Khyathi Dalal

September 25, 2023 | 8:34 pm

CLNN

Clene Inc. (NASDAQ:CLNN) has released long-term follow-up data for patients treated with CNM-Au8 30mg in the HEALEY ALS Platform Trial, showing significantly improved survival and a 49% decreased risk of death. In a pooled analysis of the HEALEY ALS Platform Trial and the RESCUE-ALS Trial, participants demonstrated a statistically significant 59% decreased risk of death compared to placebo patients. No serious adverse events have been related to CNM-Au8 treatment. The company's shares were up 0.22% at $0.46 on the last check Monday.

Portfolio Pulse from Vandana Singh

September 25, 2023 | 8:25 pm

VAPO

Vapotherm Inc (NASDAQ:VAPO) announced the results of a clinical trial showing its high flow humidified oxygen therapy to be more effective than standard oxygen therapy in treating children with acute severe asthma. The study found that fewer children treated with Vapotherm's therapy required escalation of treatment and met hospital discharge criteria sooner. Despite the positive trial results, VAPO shares are down 3.85%.

Portfolio Pulse from Vandana Singh

September 25, 2023 | 8:16 pm

LQDA

Liquidia has announced that the Generic Drug Administration (GDA) has accepted for review the company's amendment to the Tentatively Approved New Drug Application (NDA) for YUTREPIA.

Portfolio Pulse from Bill Haddad

September 25, 2023 | 8:11 pm